Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting - Segment Reporting Financial Information (Details)

v3.23.3
Segment Reporting - Segment Reporting Financial Information (Details) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Segment Reporting Information [Line Items]    
Revenues $ 28,300,820 $ 22,236,751
Depreciation and amortization 2,215,055 1,336,656
Segment operating income (653,109) (38,709)
Other income (expense), net 3,821,162 (16,147)
Income (loss) before income tax benefit 3,168,053 (54,856)
Operating Segments    
Segment Reporting Information [Line Items]    
Segment operating income 4,119,846 4,102,891
Unallocated corporate    
Segment Reporting Information [Line Items]    
Segment operating income (4,772,955) (4,141,600)
Corporate clinics    
Segment Reporting Information [Line Items]    
Revenues 17,127,957 12,606,999
Corporate clinics | Operating Segments    
Segment Reporting Information [Line Items]    
Depreciation and amortization 1,927,091 1,083,676
Segment operating income (422,053) (145,544)
Franchise operations    
Segment Reporting Information [Line Items]    
Revenues 11,172,863 9,629,752
Franchise operations | Operating Segments    
Segment Reporting Information [Line Items]    
Depreciation and amortization 198,974 173,487
Segment operating income 4,541,899 4,248,435
Corporate administration    
Segment Reporting Information [Line Items]    
Depreciation and amortization $ 88,990 $ 79,493